PL1794165T3 - Sposób wytwarzania analgetyków opioidowych przez reduktywne alkilowanie - Google Patents

Sposób wytwarzania analgetyków opioidowych przez reduktywne alkilowanie

Info

Publication number
PL1794165T3
PL1794165T3 PL05782842T PL05782842T PL1794165T3 PL 1794165 T3 PL1794165 T3 PL 1794165T3 PL 05782842 T PL05782842 T PL 05782842T PL 05782842 T PL05782842 T PL 05782842T PL 1794165 T3 PL1794165 T3 PL 1794165T3
Authority
PL
Poland
Prior art keywords
reductive alkylation
preparation
opiate analgesics
protected
hydroxyl group
Prior art date
Application number
PL05782842T
Other languages
English (en)
Other versions
PL1794165T5 (pl
Inventor
Neil John Goodwin
Melville Mitchell
Neil Kenneth Thomson
George Scott Wilson
Maureen Joan Young
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33427785&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1794165(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of PL1794165T3 publication Critical patent/PL1794165T3/pl
Publication of PL1794165T5 publication Critical patent/PL1794165T5/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL05782842T 2004-09-30 2005-09-14 Sposób wytwarzania analgetyków opioidowych przez reduktywne alkilowanie PL1794165T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0421687.5A GB0421687D0 (en) 2004-09-30 2004-09-30 Preparation of opiate analgesics
EP05782842.8A EP1794165B2 (en) 2004-09-30 2005-09-14 Preparation of opiate analgesics by reductive alkylation
PCT/GB2005/003547 WO2006035195A1 (en) 2004-09-30 2005-09-14 Preparation of opiate analgesics by reductive alkylation

Publications (2)

Publication Number Publication Date
PL1794165T3 true PL1794165T3 (pl) 2009-09-30
PL1794165T5 PL1794165T5 (pl) 2020-11-16

Family

ID=33427785

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05782842T PL1794165T5 (pl) 2004-09-30 2005-09-14 Sposób wytwarzania analgetyków opioidowych przez reduktywne alkilowanie

Country Status (13)

Country Link
US (2) US8119803B2 (pl)
EP (1) EP1794165B2 (pl)
CN (1) CN101027307B (pl)
AT (1) ATE428715T1 (pl)
AU (1) AU2005288728B2 (pl)
DE (1) DE602005013986D1 (pl)
DK (1) DK1794165T4 (pl)
ES (1) ES2322486T5 (pl)
GB (1) GB0421687D0 (pl)
PL (1) PL1794165T5 (pl)
PT (1) PT1794165E (pl)
WO (1) WO2006035195A1 (pl)
ZA (1) ZA200701784B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007137785A2 (en) * 2006-05-25 2007-12-06 Alpharma (Bermuda) Investments Ltd Process useful in the preparation of morphinan antagonists
GB2444052A (en) * 2006-05-25 2008-05-28 Alpharma Aps Processes of preparing morphinan derivatives such as naltrexone and naloxone comprising O- and N-demethylation and reductive alkylation steps
GB2471801B (en) * 2006-05-25 2011-02-16 Alpharma Process useful in the preparation of morphine antagonists
GB2471800B (en) * 2006-05-25 2011-03-09 Alpharma Preparation of N-alkylated morphinans by reduction of an iminium group
KR100780932B1 (ko) * 2006-05-30 2007-11-30 엠텍비젼 주식회사 컬러 보간 방법 및 장치
AU2008207580B2 (en) 2007-05-04 2011-04-14 SpecGx LLC Improved process for the preparation of 6-alpha-hydroxy-N-alkylated opiates
US8962841B2 (en) * 2007-06-29 2015-02-24 Brock University Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
NZ582668A (en) * 2007-07-17 2012-02-24 Mallinckrodt Llc Preparation of n-alkylated opiates by reductive amination
EP2112152A1 (en) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones as Plk Inhibitors
WO2010039220A1 (en) 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the production of buprenorphine with reduced impurity formation
US8273887B2 (en) * 2008-09-30 2012-09-25 Mallinckrodt Llc Processes for synthesis of opiate alkaloid derivatives
NZ607842A (en) * 2008-09-30 2013-12-20 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
AU2010216150B2 (en) * 2009-02-17 2015-05-14 Mallinckrodt Llc Process for the reductive alkylation of normorphinans
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
PL2440562T3 (pl) * 2009-06-11 2017-07-31 Mallinckrodt Llc Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru
ES2465066T3 (es) * 2009-06-11 2014-06-05 Mallinckrodt Llc Aminación reductora de 6-ceto-normorfinanos por transferencia de hidrógeno catalítica
GB0914338D0 (en) 2009-08-17 2009-09-30 Johnson Matthey Plc Improved process
MX2013013634A (es) 2011-06-09 2013-12-12 Mallinckrodt Llc Aminacion reductiva de 6-ceto-morfinanos por transfrencia catalitica de hidrogeno.
JP2014526467A (ja) 2011-09-08 2014-10-06 マリンクロッド エルエルシー 中間体の単離なしでのアルカロイドの調製
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides
US8937084B2 (en) 2012-12-14 2015-01-20 Purdue Pharma L.P. Nitrogen containing morphinan derivatives and the use thereof
ES2621305T3 (es) 2012-12-14 2017-07-03 Purdue Pharma Lp Morfinanos espirocíclicos y su uso
CA2894963A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
TW201441199A (zh) 2012-12-28 2014-11-01 Purdue Pharma Lp 經取代之嗎啡喃類及其用途
WO2014102587A1 (en) 2012-12-28 2014-07-03 Purdue Pharma L.P. 7,8-cyclicmorphinan analogs
US9834562B2 (en) 2012-12-31 2017-12-05 Rhodes Technologies 7 beta-substituted 6a, 14a-ethenomorphinans and 7beta-substituted 6a, 14a-ethanomorphinans
GB201313915D0 (en) 2013-08-02 2013-09-18 Johnson Matthey Plc Process
WO2015066443A1 (en) 2013-11-01 2015-05-07 Mallinckrodt Llc Convenient preparation of n-substituted morphinan-6-ols from morphinan-6-ones
ES2784690T3 (es) 2013-12-05 2020-09-29 Univ Bath Nuevos compuestos opioides y sus usos
EP3087079B1 (en) 2013-12-26 2019-04-03 Purdue Pharma LP Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
US9340542B2 (en) 2013-12-26 2016-05-17 Purdue Pharma L.P. Propellane-based compounds and the use thereof
WO2015097548A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
WO2015097547A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 10-substituted morphinan hydantoins
WO2015102682A1 (en) 2013-12-30 2015-07-09 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
MX2019007327A (es) 2016-12-23 2019-09-02 Minoryx Therapeutics S L Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil] etoxi]fenil]metil]-2,4-tiazolidindiona y sus sales.
AU2019224127B2 (en) 2018-02-23 2021-12-09 Rhodes Technologies Novel opioid compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1136214A (en) 1965-06-15 1968-12-11 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
US3717643A (en) * 1967-05-04 1973-02-20 Sterling Drug Inc N-substituted-norapomorphines
DE2107989A1 (de) * 1971-02-19 1972-09-07 Boehringer Sohn Ingelheim N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung
US4082744A (en) * 1973-05-08 1978-04-04 Nihon Iyakuhin Kogyo Co., Ltd. 4-benzazonine derivatives and process for preparation thereof
US4190601A (en) 1978-05-31 1980-02-26 Union Carbide Corporation Production of tertiary amines by reductive alkylation
IE52502B1 (en) 1981-03-27 1987-11-25 Wyeth John & Brother Ltd Morpholines
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates

Also Published As

Publication number Publication date
PT1794165E (pt) 2009-05-06
US8318937B2 (en) 2012-11-27
GB0421687D0 (en) 2004-11-03
DK1794165T4 (da) 2020-07-13
ES2322486T3 (es) 2009-06-22
EP1794165B1 (en) 2009-04-15
ATE428715T1 (de) 2009-05-15
AU2005288728B2 (en) 2012-05-03
AU2005288728A1 (en) 2006-04-06
DK1794165T3 (da) 2010-03-08
ES2322486T5 (es) 2021-02-05
DE602005013986D1 (de) 2009-05-28
PL1794165T5 (pl) 2020-11-16
ZA200701784B (en) 2008-11-26
WO2006035195A1 (en) 2006-04-06
CN101027307B (zh) 2011-12-21
EP1794165A1 (en) 2007-06-13
US8119803B2 (en) 2012-02-21
CN101027307A (zh) 2007-08-29
US20080045715A1 (en) 2008-02-21
US20120046466A9 (en) 2012-02-23
US20110144341A1 (en) 2011-06-16
EP1794165B2 (en) 2020-04-29

Similar Documents

Publication Publication Date Title
PT1794165E (pt) Preparação de analgésicos opiáceos por alquilação redutiva
GB2463981B (en) Process for the preparation of vitamin K2
IN2014CN00613A (pl)
MX9701253A (es) Compuesto de fenol y procedimiento para preparar el mismo.
WO2009038740A3 (en) Synthesis of high activity zsm-48
MY139475A (en) Process for the preparation of (1s)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid addition salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts
MX2009003698A (es) Preparacion de azoxistrobina.
GEP20084361B (en) Piperidinylcarbonyl-pyrro-lidines and their use as melanocortin agonists
NZ593882A (en) Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
YU64202A (sh) Postupak za pripremanje klaritromicina i intermedijera klaritromicina, klaritromicina u osnovi bez oksima i farmaceutskog preparata koji ga sadrži
WO2010100133A3 (fr) Derives indoliques pour le traitement de maladies neurodegeneratives
MX2007012263A (es) Produccion de (co) agentes tensioactivos al hacer reaccionar polioles con olefinas.
WO2007144780A3 (en) Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof
DE50105454D1 (de) Verfahren zur katalytischen Reduktion von Alkinverbindungen
BG100884A (en) Benzamide derivative, compositions containing said derivative and use thereof
MXPA05011193A (es) Compuestos iniciales para producir poliuretanos.
WO2007003528A3 (en) Metallocene compounds
EP1849467A4 (en) SYNERGIC PHARMACEUTICAL PREPARATION CONTAINING BAICALEIN AND BAICALIN AND INTENDED FOR INHIBITION OF A TUMOR
EP1688419A4 (en) NEW CONNECTION AND MEDICAL COMPOSITION
WO2003087048A3 (en) Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds
WO2004089870A3 (en) Process for producing alkylated diphenylamines
WO2002057251A3 (en) Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
UA94764C2 (ru) Способ получения ароматических аминов в присутствии комплекса палладия, который включает ферроценилбифосфиновый лиганд
TW200643000A (en) Reaction product of resorcin and methyl ethyl ketone
UA98151C2 (ru) СПОСОБ СИНТЕЗА 9α-ГИДРОКСИСТЕРОИДОВ